Global Accelerator for Paediatric Formulations 2022–2024 Business Plan

Launched in 2020, the Global Accelerator for Paediatric Formulations (GAP-f) has catalysed the response to the 2016 World Health Assembly Resolution 69.20 on promoting innovation and access to quality, safe, efficacious and affordable medicines for children. 

The GAP-f 2022-2024 Business Plan sets out our path to shape and accelerate the global innovation and access landscape for better paediatric medicines in concrete and substantial ways. This new plan helps to focus our work via three main strategic pillars – prioritize & align, accelerate, and intervene.

Flagship projects include the paediatric data hub, innovative technologies, regulatory pathway best practices, and a focus on child friendly treatments across various diseases.